Company Overview of QR Pharma, Inc.
QR Pharma, Inc. develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases. It offers Posiphen compound for mild cognitive impairment and early stage Alzheimer's disease; and Bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. QR Pharma, Inc. was founded in 2008 and is based in Berwyn, Pennsylvania.
1055 Westlakes Drive
Berwyn, PA 19312
Founded in 2008
Key Executives for QR Pharma, Inc.
Similar Private Companies By Industry
|Niche Pharmaceuticals Inc||United States|
|Palkion Inc.||United States|
|Inspiration Biopharmaceuticals, Inc.||United States|
|Smith-Collins Pharmaceutical, Inc.||United States|
|Regent GLSC Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact QR Pharma, Inc., please visit www.qrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.